Mary van den Berg-Wolf
- Infectious Diseases top 5%
- Virology top 2%
- Emergency Medicine top 5%
- Epidemiology
- Physiology
- Co-authors
- Alan R. LifsonAnn M. LabriolaTimothy R.H. ReadJosé Ramón ArribasJacqueline NeuhausRodger D. MacArthurGrace PengRichard M. Novak
- Topics
- HIV/AIDS Research and Interventions (10 papers)HIV Research and Treatment (8 papers)HIV/AIDS drug development and treatment (8 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Mary van den Berg-Wolf
14 papers receiving 625 citations
Peers
Comparison fields: 5 of 66
- Infectious Diseases 504
- Virology 334
- Emergency Medicine 163
- Epidemiology 135
- Physiology 102
Countries citing papers authored by Mary van den Berg-Wolf
This map shows the geographic impact of Mary van den Berg-Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary van den Berg-Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary van den Berg-Wolf more than expected).
Fields of papers citing papers by Mary van den Berg-Wolf
This network shows the impact of papers produced by Mary van den Berg-Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary van den Berg-Wolf. The network helps show where Mary van den Berg-Wolf may publish in the future.
Co-authorship network of co-authors of Mary van den Berg-Wolf
This figure shows the co-authorship network connecting the top 25 collaborators of Mary van den Berg-Wolf. A scholar is included among the top collaborators of Mary van den Berg-Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary van den Berg-Wolf. Mary van den Berg-Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 18 | |
| 6 | 220 | |
| 7 | 45 | |
| 8 | 18 | |
| 9 | 35 | |
| 10 | 41 | |
| 11 | 101 | |
| 12 | 104 | |
| 13 | 10 | |
| 14 | 31 |
About Mary van den Berg-Wolf
Mary van den Berg-Wolf is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 14 papers that have together received 645 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Virology (334 citations), Infectious Diseases (504 citations) and Emergency Medicine (163 citations). Mary van den Berg-Wolf has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Alan R. Lifson, Ann M. Labriola, Timothy R.H. Read, José Ramón Arribas, Jacqueline Neuhaus, Rodger D. MacArthur, Grace Peng, Richard M. Novak, Michael J. Kozal and Katherine Huppler Hullsiek. Their work appears in journals such as The Lancet, Clinical Infectious Diseases and American Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.